Research / ACCS / Fundamental state Inspectable configuration
State dimensions Filing 0000843006-25-000041 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
53.05% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
Operating cash generation 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
2.40% · OPTIONAL · VALID
Revenue growth 5th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-26.88% · CORE · VALID
Gross margin 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
76.23% · CORE · VALID
Operating margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-4.43% · CORE · VALID
R&D intensity 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.65% · OPTIONAL · VALID
SBC intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.73% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 70 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 7/8 normalized Level 3 Dec 31, 2024 6/7 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 58.36%
Current 53.05%
Delta -5.31% Capex Intensity Decreased
Previous 0.22%
Current 0.00%
Delta -0.22% Cash Generation Decreased
Previous 13.64%
Current 2.40%
Delta -11.24% Growth Decreased
Previous -21.34%
Current -26.88%
Delta -5.53% Margin Decreased
Previous 78.03%
Current 76.23%
Delta -1.80% Profitability Increased
Previous -12.36%
Current -4.43%
Delta 7.93% R And D Intensity Decreased
Previous 13.39%
Current 11.65%
Delta -1.73% Sbc Intensity Increased
Previous 3.71%
Current 4.73%
Delta 1.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.